Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH, GOVERNMENT CONTRACTS, MISCELLANEOUS, Philanthropy

CIVIL SOCIETY LEADERS URGE ACTION ON DEBT, INFLATION, AND CLIMATE CHANGE, RENEW CALLS FOR RUSSIA TO BE HELD ACCOUNTABLE FOR WAR CRIMES


New York, Sept. 08, 2022 (GLOBE NEWSWIRE) -- As world leaders gather for the United Nations General Assembly, the Open Society Foundations is calling for bold steps to address critical worldwide crises, including:

"Tomorrow, and tomorrow, and tomorrow isn't just a line from Macbeth," said Mark Malloch-Brown, President of the Open Society Foundations. "For too long, it has also been at the heart of world leaders' plan to tackle these mounting global challenges. That has to change."

Malloch-Brown and other Open Society Foundations representatives will be in New York in September and are available to comment on the above:

The Open Society Foundations, founded by George Soros, is the world's leading funder of independent groups working for justice, democratic governance, and human rights.



These press releases may also interest you

at 07:45
Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced results for the first quarter 2024. In a concurrent press release accompanying Agenus' earnings announcement, a $100M...

at 07:45
Crescent Innovations Inc. announced today the sale of its technology related to bone regeneration, plus various intellectual property and know-how assets. Chris Finn, President of the advisory firm Alternotio announced today that Crescent Innovations...

at 07:40
One year since forming its Advisory Board, Lokavant, the clinical trial intelligence platform company, announces three new members, including Pfizer's Head of Predictive Analytics Jonathan Crowther. The Lokavant Advisory Board brings together...

at 07:39
Lucid Diagnostics Inc.  ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc....

at 07:35
Ligand Pharmaceuticals Incorporated and Agenus Inc. , a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the companies have entered into a royalty financing agreement to support Agenus'...

at 07:35
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference...



News published on and distributed by: